Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of immediate taxane‐based chemohormonal therapy for newly diagnosed metastatic hormone‐sensitive prostate cancer.